1 / 18

Bronchial Asthma: Causes, Symptoms, and Management"

Bronchial asthma is a chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to breathing difficulties. Symptoms include wheezing, shortness of breath, chest tightness, and persistent cough, often triggered by allergens, respiratory infections, exercise, or irritants. The condition involves intermittent episodes of airway constriction, which can vary in severity. Diagnosis typically involves clinical evaluation and spirometry testing to assess lung function.<br>https://www.pnytrainings.com/<br>

Abdullah168
Télécharger la présentation

Bronchial Asthma: Causes, Symptoms, and Management"

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ASTHMA

  2. Group “D” M. Ahmad Mansoor Abu-Baker M. Ahmad M. Ahmad Jameel Arkam Ali Rehan Hussain Abdullah Hammad Junaid Akram Nouman Ali M. Abdullah M. Shoaib Prepared By: M. Ahmad Mansoor Presented By : Abu-Baker

  3. Bronchial Asthma 01 Contents Table of Drugs of Bronchial Asthma 02

  4. Bronchial Asthma “Bronchial Asthma is defined as a Chronic inflammatory disorder of the “Bronchial Asthma is defined as a Chronic inflammatory disorder of the airways which manifests itself as recurrent episodes of wheezing, airways which manifests itself as recurrent episodes of wheezing, breathlessness, chest tightness and cough.” breathlessness, chest tightness and cough.” • •It is characterized by Bronchial hyper-responsiveness and variable airflow obstruction.

  5. Causes of Asthma 1. Genetic predisposition 2. Allergens (e.g., pollen, dust mites, pet dander, mold) 3. Respiratory infections 4. Air pollution 5. Occupational exposure to irritants 6. Obesity 7. Diet 8. Exercise 9. Cold air

  6. Symptoms of Asthma 1. Shortness of breath 2. Chest tightness or pain 3. Wheezing (a whistling sound when exhaling) 4. Coughing 5. Trouble sleeping due to breathing problems

  7. CLASSIFICATION 1). Atopic/extrinsic/allergic (70%): • Most common type • Environmental agent: dust, pollen, food, animal dander • Family history - present • Serum IgE levels: Increased • Skin test with offending agent-wheal flare 2).Non-atopic/ intrinsic/non-allergic(30%) • Triggered by respiratory tract infection • Viruses - most common cause • Family history uncommon • IgE level normal • No associated allergy • Skin tests NEGATIVE • Cause- hyperirritability of bronchial tree

  8. CLASSIFICATION 3). Drug induced asthma • Several pharmacologic agents • Aspirin sensitive asthma • Increased bronchoconstrictor, leukotrienes. • Sensitive to small doses of aspirin. • Inhibits COX pathway, without affecting LPO pathway.

  9. APPROACHES TO TREATMENT 1. Prevention of AG:AB reaction: Avoidance of antigen, hypo sensitization-possible in extrinsic asthma and if antigen can be identified. 2. Neutralization of IgE (reaginic antibody): Omalizumab 3. Suppression of inflammation and bronchial hyperreactivity: Corticosteroids. 4. Prevention of release of mediators: Mast cell stabilizers. 5. Antagonism of released mediators: Leukotriene antagonists, Antihistamines, PAF antagonists. 6. Blockade of constrictor neurotransmitter: Anticholinergics. 7. Mimicking dilator neurotransmitter: Sympathomimetics. 8. Directly acting bronchodilators: Methylxanthines.

  10. Drugs I. BRONCHODILATORS A. B2 Sympathomimetics: Salbutamol, Terbutaline, Bambuterol, Salmeterol, Formoterol. B. Methylxanthines: Theophylline (anhydrous), Aminophylline, Choline theophyllinate, Hydroxyethyl theophylline, Theophylline ethanolate of piperazine, Doxophylline. C. Anticholinergics: Ipratropium bromide, Tiotropium bromide. II. LEUKOTRIENE ANTAGONISTS Montelukast, Zafirlukast. III. MAST CELL STABILIZERS Sodium cromoglycate, Ketotifen. IV. CORTICOSTEROIDS A. Systemic: Hydrocortisone, Prednisolone and others. B. Inhalational: Beclomethasone dipropionate, Budesonide, Fluticasone propionate, Flunisolide, Ciclesonide. V. ANTI-IgE ANTIBODY Omalizumab

  11. MECHANISM OF BRONCHODILATION

  12. MECHANISM OF LEUKOTRIENE ANTAGONISTS

  13. MECHANISM OF MAST CELL STABILIZERS

  14. MECHANISM OF CORTICOSTEROIDS

  15. MECHANISM OF CORTICOSTEROIDS

  16. MECHANISM OF ANTI-IgE ANTIBODY

  17. SIDE EFFECTS OF DRUG • Nervousness • Dizziness • Headache • Tremor • Weight gain • Dry mouth

  18. THANKS

More Related